Animal Bioscience

What Animal Bioscience does

Animal Bioscience Inc. is a Boston-based, pre-commercialisation animal health company developing therapeutics and supplements that target aging at the cellular level in companion animals — primarily dogs, cats, and horses. Founded in 2017 and operating with 1–10 employees, the company applies longevity science originally developed in human medicine (NAD+ boosting, senolytic/senostatic peptides) to extend healthspan and lifespan in pets. Its lead commercial-facing product is Leap Years™, a chewable NAD+ boosting supplement for dogs aged 4–7+ that the company positions as part of a broader "Cellular Longevity System" integrating oral supplementation with wearable monitoring. The underlying technology targets two mechanisms: restoration of NAD+ levels (which decline with age) and removal/management of senescent cells that drive chronic inflammation. The company is conducting clinical trials with North Carolina State University College of Veterinary Medicine to validate efficacy, using Dinbeat's DinbeatPRO wireless wearable harness to capture longitudinal physiological and behavioral data on aging dogs.

The business model is a dual-channel consumer and professional distribution approach. On the consumer side, Animal Bioscience sells Leap Years directly to pet owners through a dedicated e-commerce storefront at leapyears.com, with marketing driven through the company website, email newsletters, and social media (Facebook, Instagram, Twitter, Reddit, YouTube). On the professional side, the company engages veterinarians through dedicated outreach ([email protected]), clinical trial participation, and recommendations for senior canine patients. Pricing is not publicly disclosed. Revenue is one-time product sales (supplements and clinical-use products), with no subscription or licensing model indicated. The company has raised approximately $2.33M across two funding rounds, with the most recent in January 2022. Prof. David Sinclair of Harvard Medical School serves as Founder/Advisor, and Longevitytech.fund and Kline Hill Partners are represented on the board.

Animal Bioscience is led by CEO and Chief Veterinary Medical Officer Ginny Rentko (VMD, Diplomate ACVIM, former Tufts Medical Director and Biopure VP), CFO Brian Malone (former Longwood Fund Management CFO and Axial Biotherapeutics SVP Finance), and a board including Petr Sramek (Longevitytech.fund), Nick Sinclair, and Jared Barlow (Kline Hill Partners). The company describes itself as "global" and operates from a single Boston headquarters at 361 Newbury Street. To date, the company remains pre-commercialisation with no disclosed revenue and no FDA-reviewed or approved products, with ongoing research and clinical validation representing the dominant share of activity.

Name

Animal Bioscience

Legal name

Animal Bioscience Inc.

Website

https://animalbioscience.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

Animal Bioscience is a pre-commercialisation animal health company developing NAD+ boosting supplements and senolytic therapies to extend healthspan and lifespan in companion animals, primarily dogs, with its lead product Leap Years sold direct-to-consumer online.

Ownership category

akta.pro rank

Product category

Pet Nutraceuticals

NAICS

Animal Food Manufacturing (3111)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Species-Specific Supplements (Dog/Cat/Other Companion Species) (HLAMALAN)

akta.pro secondary industries

Senior & Cognitive Support Supplements (HLAMALAJ), Cardiac & Circulatory Support Supplements (HLAMALAK)

Keywords

• Pet longevity supplements
• Animal cellular health
• Companion animal therapeutics
• Veterinary nutraceuticals
• Cellular aging research

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Leap Years Supplements: Sale of chewable cellular longevity supplements for dogs through e-commerce platform. Product is sold directly to pet owners targeting age-related disease prevention and healthspan extension.
2. Veterinary Product Sales: Distribution of therapeutic and supplement products through veterinary channels for clinical use in treating age-related conditions in companion animals.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Animal Bioscience develops and sells Leap Years™, a chewable NAD+ (nicotinamide adenine dinucleotide) boosting cellular longevity supplement for dogs that targets age-related cellular decline to extend healthspan and vitality. The Leap Years™ Cellular Longevity System combines this proprietary oral supplement formulation with DinbeatPRO wearable monitoring to measure and assess combined effects on mental and physical qualities in aging dogs. The company also develops proprietary combination therapeutic products evaluated in clinical trials for age-related diseases in companion animals (dogs, cats, horses) through academic collaborations, and engages veterinarian networks for clinical recommendations and trial participation.

Product overview

Animal Bioscience Inc. is a global, pre-commercialization animal health company focused on increasing longevity (years of life) and healthspan (quality of life) in companion animals, primarily dogs. Its consumer-facing product is Leap Years™ (also referred to as the Leap Years™ Cellular Longevity System), a two-part system combining a proprietary oral NAD+ boosting supplement with wearable technology data collection to extend health and vitality in aging dogs. The company also operates a separate research pipeline studying proprietary combination products for age-related conditions in partnership with academic institutions.

Differentiator

Problem solved

Functional benefit

Brands

• Leap Years™: Cellular longevity system for dogs - a scientifically proven chewable supplement that improves vitality and addresses age-related conditions by boosting NAD+ levels at the cellular level

Products and services

• Leap Years™ Cellular Longevity Supplement for Dogs A chewable NAD+ (nicotinamide adenine adenine dinucleotide) boosting cellular longevity supplement for dogs that improves vitality and addresses age-related conditions at the cellular level. The proprietary oral formulation is clinically tested with proven absorption and bloodstream bioavailability, manufactured to pharmaceutical-grade (GMP) standards, and is targeted at dog owners seeking to extend healthspan and quality of life in senior dogs.
• Proprietary Combination Product (Clinical Pipeline) A proprietary combination therapeutic product under clinical evaluation in aged companion animals, studied in partnership with North Carolina State University College of Veterinary Medicine to assess effects on activity and attention in aging dogs using wearable health monitoring data collection.

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• DinbeatcoreTechnology or IntegrationDinbeat is a technology partner providing wearable health monitoring devices for pets. They developed the DinbeatPRO, a multi-parameter wireless harness that tracks pet performance and biology to medical standards, monitoring ECG, heart rate, breath per minute, and temperature. This partnership enables data collection on physical activity and behavior changes in dogs using Animal Bioscience products.
• North Carolina State University College of Veterinary MedicinecoreStrategic or Co-development PartnerCollaborative clinical trial partnership studying the effects of Animal Bioscience's proprietary dietary supplement combination on activity and attention in aging pet dogs. The university is gathering data using wearable technology to assess changes in senior dogs over time, validating the efficacy of the cellular longevity system.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Loyal for Dogs: Loyal is developing FDA-approved pharmaceutical drugs to extend dog lifespan and healthspan, the closest direct peer to Animal Bioscience's cellular longevity thesis for dogs but operating through a drug development pathway rather than supplements.
• Pet Honesty: Premium DTC pet supplement brand selling chews and functional supplements (joint, skin, calming, immune) directly to dog owners, overlapping with Leap Years' DTC supplement channel and target demographic.
• Zesty Paws: One of the largest premium pet supplement brands in the U.S., offering functional chews targeting joint, skin, calming, and senior dog health — directly competitive with Animal Bioscience's senior dog positioning.
• Nutramax Laboratories: Veterinary-channel-focused pet supplement maker (Cosequin, Denamarin, Dasuquin) selling through vet clinics and specialty retail, comparable to Animal Bioscience's veterinary distribution motion for aging dogs.
• Tomlyn (Vetoquinol): Veterinary nutraceutical brand offering supplements for dogs and cats across joint, calming, immune and senior health — overlaps with Leap Years' senior dog and cellular health positioning.
• Petlab Co. DTC pet supplement brand selling joint, dental, calming and probiotics chews through subscription, directly comparable to Leap Years' DTC subscription economics and senior dog customer segment.

Broad incumbents

• Hill's Pet Nutrition: Veterinary-channel incumbent with prescription and 'Science Diet' therapeutic diets targeted at age-related conditions in dogs, competing for vet recommendation share that Animal Bioscience is also pursuing.
• Royal Canin: Global premium pet nutrition brand with breed- and life-stage-specific diets, including senior dog formulations, competing in the same veterinary and specialty retail channels.
• Purina Pro Plan (Nestlé): Mass-market premium pet nutrition brand with veterinary lines (Bright Mind, NeuroCare) targeting cognitive aging in dogs, the most direct mass-market incumbent to Leap Years' senior/cognitive positioning.

Others

• Dinbeat: Animal Bioscience's wearable technology partner; comparable because Dinbeat also serves the pet health monitoring category, but the relationship is supplier/integration rather than competitive.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/animalbiosci
• YouTubeyoutube.com/animalbioscience
• Facebookfacebook.com/animalbioscience
• Instagraminstagram.com/animal_bioscience

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Animal Bioscience